1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1. Drivers
4.1.1. Growing awareness about the benefits of cell Culture-based vaccines
4.1.2 Increasing demand for monoclonal antibodies
4.1.3 Funding for cell-based research
4.1.4 Growing preference for single-use technologies
4.1.5 Launch of advanced cell culture products
4.2. Restraints
4.2.1. The high cost of cell biology research
4.2.2 Lack of infrastructure for cell-based research in emerging economies
4.3. Opportunities
4.3.1. Growing demand for 3d cell culture
4.3.2 Increased risk of pandemics and communicable diseases
4.3.3 Emerging economies
4.4. Challenges
4.4.1. Survival of new entrants
5. Asia Pacific Cell Culture Market– By Product
5.1. Equipment
5.1.1. Bioreactors
5.1.1.1. Conventional bioreactors
5.1.1.2 Single-use bioreactors
5.1.2 Vessels
5.2.2.1 Flasks
5.2.2.2 Roller/Roux bottles
5.2.2.3 Others
5.1.3 Storage equipment
5.2.3.1 Refrigerators and freezers
5.2.3.2 Cryostorage systems
5.1.4 Supporting equipment
5.1.4.1 Cell counters
5.1.4.2 Filtration systems
5.1.4.3 Others
5.2 Consumables
5.2.1 Sera, media, and reagents
5.2.1.1 Sera
5.2.1.1.1 Fetal Bovine Sera (FBS)
5.2.1.1.2 Adult Bovine Sera (ABS)
5.2.1.1.3 Other Animal Sera
5.2.1.2 Media
5.2.1.2.1 Classical Media & Salts
5.2.1.2.2 Serum-Free Media
5.2.1.2.3 Specialty Media
5.2.1.2.4 Stem Cell Culture Media
5.2.1.3 Cell Culture Reagents
5.2.1.3.1 Supplements and Growth Factors
5.2.1.3.2 Buffers and Chemicals
5.2.1.3.3 Cell Dissociation Reagents
5.2.1.3.4 Balanced Salt Solutions
5.2.1.3.5 Others
6. Asia Pacific Cell Culture Market– By Application
6.1. Biopharmaceutical/Therapeutic Applications
6.2.1 Vaccine Production
6.2.2 Diagnostics
6.2.3 Recombinant Therapeutic Proteins
6.2 Cancer Research
6.3 Stem Cell Technologies
6.4 Drug Screening & Development
6.5 Tissue Engineering & Regenerative Medicine
6.6 Other Applications
7. Asia Pacific Cell Culture Market- By End-user
7.1. Pharmaceutical & Biotechnology Companies
7.2. Research Institutes
8. Asia Pacific Cell Culture Market– By Geography
8.1. Introduction
8.2. Asia Pacific
8.2.1. China
8.2.2. Japan
8.2.3. India
8.2.4. Australia & New Zealand
8.2.5. South Korea
8.2.6. Others
9. Asia Pacific Cell Culture Market– Company Profiles
9.1 Thermo Fisher Scientific
9.2 Merck KGaA
9.3 Ge Healthcare (A Subsidiary of General Electric Company)
9.4 Lonza Group AG
9.5 Corning
9.6 Becton, Dickinson and Company
9.7 Eppendorf
9.8 Hi-Media Laboratories
9.9 Sartorius AG
9.10 Promocell
9.11 Irvine Scientific
9.12 Danaher
10. Asia Pacific Cell Culture Market- Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
11. Market Insights
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
12. Appendix
12.1. List of tables
12.2. List of figures
